|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 412 1st Street, SE |
Address2 | Suite 3 |
City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400660986-24
|
||||||||
|
6. House ID# 414350000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: G. David Mason |
Date | 10/21/2019 4:21:22 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 (P.L. 114-10) including policies related to the Quality Payment Program
Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health
Medicare Shared Savings Program beneficiary assignment requirements
Medicare-Medicaid hospital conditions of participation
Evaluation of the Medicare Graduate Nurse Education demonstration
Medicare-Medicaid Program Integrity policies
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
Medicaid per capita cap policy options
Medicaid Extenders Act of 2019 (H.R. 259)
Promoting Access to Diabetic Shoes Act (H.R. 808/S. 237)
ACO Assignment Improvement Act of 2019 (H.R. 900)
Medicare for All Act of 2019 (H.R. 1384)
Medicaid Services Investment and Accountability Act of 2019 (H.R. 1839)
Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 (H.R. 3253)
Protect Medicaid Act (S. 131)
Home Health Care Planning Improvement Act of 2019 (S. 296/H.R. 2150)
Medicare at 50 Act (S. 470)
State Public Option Act (S. 489/H.R. 1277)
Expanding Access to Diabetes Self-Management Training Act (S. 814)
S. 2047, providing for a two-week extension of the Medicaid community mental health services demonstration program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation and policies relating to:
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Reauthorization of funding for the Childrens Health Insurance Program
Reauthorization of the Child Nutrition Act
Section 2706 of the ACA regarding provider non-discrimination
Policies related to health insurance market stabilization
Policies affecting nurse practitioner education and workforce
Definition, evaluation and enforcement of essential health benefits and provider network adequacy
Health information technology and electronic health records
Mental health services and violence prevention
Human and child trafficking
Recognizing the importance of vaccinations and immunizations in the United States (H. Res. 179)
Title VIII Nursing Workforce Reauthorization Act of 2019 (H.R. 728/S. 1399)
Emergency Medical Services for Children Program Reauthorization Act of 2019 (H.R. 776/S. 1173)
End Surprise Billing Act of 2019 (H.R. 861)
Fairness for Breastfeeding Mothers Act (H.R. 866/S. 528)
Protecting Americans with Preexisting Conditions Act of 2019 (H.R. 986)
Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019 (H.R. 987)
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect (H.R. 1010)
Autism CARES Act of 2019 (H.R. 1058)
Educating Consumers on the Risks of Short-Term Plans Act of 2019 (H.R. 1143)
Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 1309)
Personal Health Investment Today (PHIT) Act of 2019 (H.R. 1679/S. 680)
Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act (H.R. 1897)
Community Health Investment, Modernization, and Excellence Act of 2019 (H.R. 2328)
Stronger Child Abuse Prevention and Treatment Act (H.R. 2480)
Mainstreaming Addiction Treatment Act (H.R. 2482)
Newborn Screening Saves Lives Reauthorization Act of 2019 (H.R. 2507)
Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 (H.R. 2781)
VACCINES Act of 2019 (H.R. 2862)
To extend the program of block grants to States for temporary assistance for needy families and related programs through September 30, 2019 (H.R. 2940)
Safe Cribs Act of 2019 (H.R. 3170)
Safe Sleep for Babies Act of 2019 (H.R. 3172)
Sustaining Excellence in Medicaid Act of 2019 (H.R. 3253)
Pathways to Health Careers Act (H.R. 3398)
Chronic Care Management Improvement Act (H.R. 3436)
No Surprises Act (H.R. 3630)
Midwives for Maximizing Optimal Maternity Services (Midwives for MOMS) Act of 2019 (H.R. 3849)
Social Determinants Accelerator Act of 2019 (H.R. 4004)
A resolution recognizing the importance of vaccinations and immunizations in the United States (S. Res. 165)
Community and Public Health Programs Extension Act (S. 192)
National Nurse Act of 2019 (S. 696/H.R. 1597)
Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767)
Nursing Where It's Needed Act (S. 1045)
Lower Health Care Costs Act (S. 1895)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Legislation and policies relating to:
Authorization and appropriations of Title VIII funding for nurse education and nurse workforce development programs in fiscal years 2019 and 2020
FY 2019 and 2020 appropriations for antimicrobial research programs
FY 2019 and 2020 appropriations for the Childrens Hospitals Graduate Medical Education Program
FY 2019 and 2020 appropriations for the FDA Pediatric Device Consortia Grant Program
Impact of sequestration on the Health Resources and Services Administration (HRSA) and other discretionary Department of Health and Human Services spending
Further Additional Continuing Appropriations Act, 2019 (H.J. Res. 28)
Consolidated Appropriations Act, 2019 (H.J. Res. 31)
Consolidated Appropriations Act, 2019 (H.R. 21)
Financial Services and General Government Appropriations Act, 2019 (H.R. 264)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019 (H.R. 265)
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019 (H.R. 266)
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2019 (H.R. 267)
Supplemental Appropriations Act, 2019 (H.R. 268)
Consolidated Appropriations Act, 2019 (H.R. 648)
Investing for the People Act of 2019 (H.R. 2021)
Additional Supplemental Appropriations for Disaster Relief Act, 2019 (H.R. 2157)
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740)
Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 (H.R. 3055)
Bipartisan Budget Act of 2019 (H.R. 3877)
Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 (H.R. 4378)
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2020 and setting forth the appropriate budgetary levels for fiscal years 2021 through 2024 (S. Con. Res. 12)
Emergency Supplemental Appropriations for Humanitarian Assistance and Security at the Southern Border Act, 2019 (S. 1900)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Legislation and policies related to:
Pediatric and childrens health research
Nursing research
Gun Violence Prevention Research Act (S. 184/H.R. 674)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Legislation and policies related to:
Tax policies related to health care coverage, subsidies and exemptions
Middle Class Health Benefits Tax Repeal Act of 2019 (H.R. 748/S. 684)
Personal Health Investment Today (PHIT) Act (S. 680/H.R. 1679)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Legislation and policies related to:
Immigration, visa status, and deportation of children and families with children, including the Deferred Action for Childhood Arrivals program
Dream and Promise Act (H.R. 6)
"Homeland Security Improvement Act" (H.R. 2203)
Dream Act of 2019 (H.R. 2820)
American Promise Act of 2019 (H.R. 2821)
No Federal Funds for Public Charge Act of 2019 (H.R. 3222)
Humanitarian Standards for Individuals in Customs and Border Protection Custody Act (H.R. 3239)
U.S. Border Patrol Medical Screening Standards Act (H.R. 3525)
Relating to a national emergency declared by the President on February 15, 2019 (H.J. Res. 46)
Fairness for High-Skilled Immigrants Act (S. 386)
Secure and Protect Act (S. 1494)
A joint resolution relating to a national emergency declared by the President on February 15, 2019 (S.J. Res. 54)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Legislation and policies related to:
Accreditation and curriculum of advance practice nursing education programs
Policies and requirements related to scholarship and loan repayment programs for advanced practice registered nurses
Protecting JOBs Act (S. 609/H.R. 3689)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Legislation and policies related to:
Firearms and gun violence protections for children, families, and health care providers, including schools and health care facilities
Bipartisan Background Checks Act of 2019 (H.R. 8)
Raise the Age Act (H.R. 717)
Keep Americans Safe Act (H.R. 1186)
Background Check Expansion Act (S. 42)
Assault Weapons Ban Act of 2019 (S. 66)
Gun Violence Prevention Research Act (S. 184/H.R. 674)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Bureau of Alcohol Tobacco Firearms & Explosives
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Legislation and policies related to:
Environmental protections affecting the health and safety of children, families, and health care providers
A resolution recognizing the duty of the Federal Government to create a Green New Deal (H. Res. 109/S. Res. 59)
Recognizing the duty of the Federal Government to create a Green New Deal (S.J. Res. 8)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Legislation and policies related to:
Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices
Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices
Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019 (H.R. 2084)
Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339)
Quell Underage Inhaling of Toxic Substances (QUITS) Act of 2019 (H.R. 4425)
E-Cigarette Youth Protection Act (S. 616)
Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S. 655/H.R. 1498)
Tobacco to 21 Act (S. 1258/H.R. 2411)
Tobacco-Free Youth Act (S. 1541)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Legislation and policies related to:
Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses
National Defense Authorization Act for Fiscal Year 2020 (H.R. 2500/S. 1790)
United States Cadet Nurse Corps Service Recognition Act of 2019 (S. 997/H.R. 2056)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Legislation and policies related to:
APRN prescribing authority
Development, testing and prescribing of pediatric pharmaceuticals
Lower Drug Costs Now Act of 2019 (H.R. 3)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Legislation and policies related to:
Programs and grants to encourage greater youth physical fitness and activity, and to combat obesity
Americas Transportation Infrastructure Act of 2019 (S. 2302)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |